About

Regeneron Pharmaceuticals, Inc. is an American biotechnology company, founded in 1988 and headquartered in Tarrytown, New York, U.S. Originally focused on neurotrophic factors and their regenerative capabilities, the company has since expanded its operations into the study of both cytokine and tyrosine kinase receptors, which led to its first product, a VE GF-trap. As a public company, Regeneron reported a substantial revenue of US$ 14.20 billion in 2024, operating within the Pharmaceuticals Biotech industry.